Advertisement
ResearchIn-Press PreviewInflammationNeuroscience
Open Access | 10.1172/JCI187571
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Sánchez-Benito, L. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by González-Torres, M. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Fernández-González, I. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Cutando, L. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Royo, M. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by
Compte, J.
in:
PubMed
|
Google Scholar
|
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Vila, M. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Jurado, S. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by Sanz, E. in: PubMed | Google Scholar
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
2Institute of Neuroscience, CSIC-UMH, Alicante, Spain
3Neurodegenerative Diseases Research Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
Find articles by
Quintana, A.
in:
PubMed
|
Google Scholar
|
Published October 2, 2025 - More info
Deficits in the mitochondrial energy-generating machinery cause mitochondrial disease (MD), a group of untreatable and usually fatal disorders. Among many severe symptoms, refractory epileptic events are a common neurological presentation of MD. However, the neuronal substrates and circuits for MD-induced epilepsy remain unclear. Here, using mouse models of Leigh Syndrome, a severe form of MD associated to epilepsy, that lack mitochondrial complex I subunit NDUFS4 in a constitutive or conditional manner, we demonstrate that mitochondrial dysfunction leads to a reduction in the number of GABAergic neurons in the rostral external globus pallidus (GPe), and identify a specific affectation of pallidal Lhx6-expressing inhibitory neurons, contributing to altered GPe excitability. Our findings further reveal that viral vector-mediated Ndufs4 re-expression in the GPe effectively prevents seizures and improves the survival in the models. Additionally, we highlight the subthalamic nucleus (STN) as a critical structure in the neural circuit involved in mitochondrial epilepsy, as its inhibition effectively reduces epileptic events. Thus, we have identified a role for pallido-subthalamic projections in the development of epilepsy in the context of mitochondrial dysfunction. Our results suggest STN inhibition as a potential therapeutic intervention for refractory epilepsy in patients with MD providing promising leads in the quest to identify effective treatments.